A retrospective, comparative study was performed reviewing the electronic medical records and digital radiographs of patients who underwent treatment for intertrochanteric and pertrochanteric hip fractures with either a hip screw and side plate (HSSP) or intramedullary nail. A total of 430 patients were treated with HSSP, and 725 were managed with a cephalomedullary nail (CMN). Of these, 103 sustained a contralateral hip fracture. Fixation technique was not associated with a significant difference in the rate of contralateral fracture. Among the patients with a contralateral fracture, the median time to contralateral fracture was 119.28 months following HSSP and 81.97 months following CMN. Bisphosphonate use was found to be a significant predictor of contralateral fracture for all patients, but when matching using propensity scores, its use was found to be insignificant. In conclusion, there was no difference in the rate of subsequent contralateral hip fracture when comparing HSSP with CMN. Additionally, the time to second surgery between the two treatment modalities was found to be statistically insignificant. It is unclear if bisphosphonate use increased the odds of having a contralateral fracture, regardless of the surgical intervention. The difference in the bisphosphonate effect using propensity score matching suggests that the results may be due to confounding variables and bias. E pidemiologic studies have demonstrated that over 1.6 million US adults sustain a hip fracture yearly, and that number is expected to increase over the next 5 years (1) . Nearly 14% of Americans die within 6 months of the initial fracture, while 24% die within 12 months (2-4). Additionally, 2% to 12% of patients with a hip fracture sustain a contralateral fracture (5-12). Souder et al (12) indicated an increased risk of contralateral hip fracture after initial treatment for a femoral neck fracture with closed reduction and percutaneous pinning, as compared with arthroplasty. Zlowodzki et al (13) demonstrated that cannulated hip screw constructs for femoral neck fractures are more prone to shortening, which may decrease tension on abductors and increase the risk for falls and subsequent hip fractures. Because the type of surgical treatment aff ects the rate of subsequent fractures following femoral neck fracture, it is reasonable to believe that it would also aff ect the rate of contralateral fractures following intertrochanteric and pertrochanteric (IT/PT) fractures, which are generally treated with either hip screw and side plate constructs (HSSP) or cepha- lomedullary nails (CMN). Th e advantages, disadvantages, and outcomes following HSSP compared with CMN for IT/PT fractures have been the subject of multiple studies; however, to our knowledge, no study has compared HSSP with CMN in regards to rate of subsequent contralateral hip fracture. Th is study aimed to determine whether the type of surgical fi xation (HSSP vs CMN) for initial proximal femoral fractures (excluding neck) infl uenced the rate of contralateral hip fracture and then assessed whether bisphosphonate use, diabetes mellitus, and smoking aff ected the rate of contralateral proximal femur fractures for each treatment modality.
METHODS
Th is study was a retrospective, comparative chart review of two cohorts of patients within a single health care system (Level 3 evidence). Th is study was approved by our hospital's institutional review board prior to initiation. All patients who underwent treatment of an IT/PT proximal femur fracture (AO-Müller/Orthopaedic Trauma Association [AO/OTA] classifi cation of A1, A2, or A3) with an HSSP or CMN between January 1, 2001, and March 23, 2013, within our single level 1 trauma health care system were identifi ed. Patients who had malignant disease, sustained any fracture other than an IT/PT hip fracture of a native hip, were treated with any procedure other than HSSP or CMN, or sustained the fracture as a result of high-energy trauma were excluded from this study. High-energy trauma was defi ned as an injury resulting from any mechanism other than a fall from standing or seated height. In addition, we excluded patients with sequential bilateral hip fractures whose fi rst fracture was not managed at our facility. We were the treating facility of all hip fractures included in this retrospective review. In total, 1157 medical records met inclusion criteria and were reviewed.
All patients were managed by orthopedic senior staff surgeons. Th e orthopedic implants utilized were the Stryker Omega Dynamic Hip Screw (West Chester, PA) and the Stryker Gamma Intramedullary Locking Nail (Kalamazoo, MI). Fracture pattern Rate of contralateral hip fracture after dynamic hip screw vs intramedullary nail for treatment of pertrochanteric hip fractures based on Evans classifi cation and the AO/OTA classifi cation, as well as individual surgeon experience, infl uenced the method of treatment (14, 15) . Most AO/OTA 31-A1 and stable AO/ OTA 31-A2 fractures are treated with an HSSP at our facility, while unstable AO/OTA 31-A2 fractures are treated with a CMN. Lastly, AO/OTA 31-A3 fractures are treated with a CMN. Studies have defi ned unstable fractures as those with extension into the subtrochanteric region, comminution of the lateral wall, comminution of the posterior-medial cortex, and reverse obliquity types (16, 17) .
Postoperatively, patients were weight-bearing as tolerated and began working with physical therapists immediately. Patients were discharged home with home health or were discharged to a skilled nursing facility, nursing home, or rehabilitation center, depending on physical therapy recommendations and the amount of assistance available at home.
International Statistical Classifi cation of Diseases and Related Health Problems (ICD-9) codes were utilized to identify patients with unspecifi ed trochanteric fractures (ICD-9 820.20) and intertrochanteric fractures (ICD-9 820.21). Th e medical records were reviewed and data collected including medical record number, date of birth, gender, fracture type, surgery type, mechanism of injury, surgery date, surgeon involved, bisphosphonate use, diabetic status, and smoking status. For all those with subsequent proximal femur fractures, we recorded the time that elapsed from initial to subsequent fractures. Digital radiographs were then reviewed for each fracture to confi rm fracture type (pertrochanteric, intertrochanteric, subtrochanteric), note surgery performed (HSSP, CMN), and classify the fracture types according to the Evans and AO/OTA classifi cation system for proximal femur fractures. After radiographic review, the subtrochanteric femur fractures were excluded from the data set.
Secondary variables were collected from the patient chart: age, sex, cigarette smoking, bisphosphonate use, and history of diabetes. Smoking status was classifi ed based on a scale of 1 to 5: Grade 1 were patients who had never smoked or smoked <10 pack-years, Grade 2 were former smokers of 10 to 50 pack-years, Grade 3 were former smokers of >50 pack-years, Grade 4 were current smokers of <1 pack per day, and Grade 5 were current smokers of >1 pack per day. Signifi cant smoking history was defi ned as Grade 2 or higher.
Descriptive statistics are reported as mean (standard deviation) or median (range) for continuous variables. Categorical variables are described as counts and percentages. Outcome variables were compared by contralateral fracture and fi xation methods. Chi-square tests were used to compare two independent nominal variables. A logistic regression model was fi t to the data. A P value of 0.25 was used to select variables for the model, and the fi nal model selection used the methods of stepwise, forward, and backward selection. Profi le likelihood methods were used to calculate the confi dence intervals of the odds ratios. Due to the retrospective nature of the data, a conditional logistic regression model using one-to-one propensity score matching was performed to adjust for diff erences between the fi xation groups. Patients were matched according to a propensity score calculated using a logistic regression model on type of fi xation as a response, with gender, diabetes status, fracture type, bisphosphonate use, fi rst fracture classifi cation, and fi rst fracture side used as covariates. Th e number of digits to match in the probabilities was 0.001. A log-rank test was used for comparison of time to second fracture by fi xation technique. A level of 0.05 was considered statistically signifi cant for all tests. Th e software used was SAS/STAT, Version 9.4 of the SAS System for Windows, and StatXact version 10.1. No external funding sources were used for this retrospective review.
RESULTS
Following review of all medical records and radiographs, 1157 patients met inclusion criteria. Two of these patients had subtrochanteric extension of their fracture and were excluded from the analysis for a total of 1155 subjects. Of these, 103 (8.9%) patients had contralateral fractures. Th e study population included 841 (72.8%) females and 314 (27.2%) males with an average age of 82. 4 (10. 3) years at the time of initial hip fracture (Table 1) . Four hundred and thirty (37.2%) were managed with an HSSP and 725 (62.8%) were managed with a CMN. Demographic data for these patients are listed in Table 2 . Th e percentage of contralateral hip fractures in both HSSP and CMN groups was 8.9%, with 46 patients (10.7%) in the HSSP group and 57 patients (7.9%) in the CMN group suff ering a contralateral proximal femur fracture (P = 0.11). Among the patients with a contralateral fracture, the median time to contralateral fracture following HSSP was 119.28 (60.98-141.54) months and for CMN, 81.97 (65.57-110.30) months.
A logistic regression model was statistically significant (P = 0.014), with only bisphosphonate use as a signifi cant factor for predicting a contralateral fracture (P = 0.01; Tables  3 and 4 ). Residual diagnostics indicated no violations to the assumptions in the model, and the Hosmer-Lemeshow test pointed to an adequate fi t to the data. However, the c statistic (c = 0.58) indicated that the model was just slightly better than chance (0.5) in predicting the outcome. Th is may suggest that, although the model fi ts well and bisphosphonate use is a predictor of a contralateral fracture, there are unknown factors that could increase the prediction of a contralateral fracture. A conditional logistic regression model using bisphosphonate and type of fi xation using propensity scores for matching the patients was not signifi cant (P = 0.2). Selection of variables was performed using stepwise, forward, and backward elimination. None of the methods chose a variable in the matched analysis. Bisphosphonate and type of fi xation were added to the model for comparison with the unmatched logistic regression. Th e diff erences in the models suggest that the results may be due to confounding variables and bias. All regression diagnoses were checked and model assumptions satisfi ed.
Comparing characteristics of patients with type of surgery (HSSP vs CMN), age and fracture classifi cation were statistically signifi cant (P = 0.03 and < 0.0001, respectively).
DISCUSSION
To our knowledge, no previous studies have specifi cally compared methods of intertrochanteric and pertrochanteric hip fracture fi xation and the associated risk of subsequent contralateral hip fracture. Souder et al (12) recently reported a signifi cantly increased risk of subsequent contralateral hip fracture after treatment of a femoral neck fracture with closed reduction percutaneous pinning in comparison with hip arthroplasty. Th e purpose of this study was to report the rate of contralateral hip fracture after an initial IT/PT fracture treated with HSSP compared with CMN. One might expect this study to produce outcomes similar to those of Souder et al (12) , especially with the large number of patients and a similar database of patients. However, our results indicated no diff erence in the rate of contralateral hip fractures when treating IT/PT proximal femur fractures with HSSP compared with CMN. Regardless of type of fi xation used in these circumstances, the patient had an 8.9% chance (with a 95% confi dence interval of 7.3 to 10.7) of suffering a subsequent contralateral hip fracture.
We found bisphosphonate use to be associated with having a subsequent contralateral hip fracture (P = 0.02), but this result does not hold in a propensity score match analysis. Eighty-four patients in the HSSP group and 165 patients in the CMN group were taking bisphosphonates for a diagnosis of osteoporosis. Th e odds for a second fracture were 1.7 times greater for patients taking bisphosphonates compared with those not taking bisphosphonates.
Diabetes mellitus and smoking history did not demonstrate a statistically signifi cant association with subsequent hip fracture after the index fracture (P = 0.79 and 0.97, respectively). Th ere were more diabetic patients in the CMN group than in the HSSP group, but this diff erence was not statistically signifi cant (P = 1.0). Th is may have elevated the rate of contralateral hip fractures in this group, but our analysis did not validate this assumption.
Our data indicate that when utilizing appropriate surgical indications in the setting of AO/OTA 31-A1 and A2 IT/PT fractures, there was no diff erence in the rate of contralateral hip fractures regardless of method of fi xation. A recent literature review conducted by Kaplan et al (18) recommended fi xing unstable intertrochanteric hip fractures with a CMN due to evidence that intramedullary devices aid in early mobilization and return of ambulatory function, presumably by maintaining a better reduction and not allowing the shortening and decreased off set seen with HSSP fi xation (19, 20) . Kaplan does not stand alone, as several other prospective randomized trials have supported a better preservation of reduction when nails are used (21) (22) (23) . Th e two surgical groups, however, were not entirely comparable; 31-A1 fractures were treated more often with HSSP, while 31-A2 fractures were treated more often with CMN. Our results do not suggest that highly unstable fractures treated with either HSSP or CMN will have a similar contralateral fracture rate. Even when CMN nails are used to fi x more complex and potentially unstable fracture patterns, a similar rate of contralateral fracture is seen compared with HSSP when utilized in less severe fracture patterns.
Th ere was no diff erence in the distribution of age in patients that had a second fracture. Current reports also indicate that the older the patients, the more likely they are to sustain both an index fracture and a subsequent hip fracture (24, 25) . Overall, the median age of our cohort at the time of their initial hip fracture was 82.4 years for both the HSSP and CMN group; the median age of the cohort that sustained a contralateral fracture at the time of their initial hip fracture was 81.8 years. Th e average age of a contralateral fracture in 103 patients was 83.6 years. Th ese data are in line with current literature that reports an average age of 77 ± 6.7 years and 80 ± 6.4 years at the time of initial and second fracture, respectively (11) .
Both treatment groups experienced a similar median length of time until they suff ered a contralateral hip fracture (HSSP was 9.9 years and CMN was 6.8 years; P = 0.62). A literature review found a wide range of data with intervals from initial to subsequent fracture between 2 and 7+ years (11, 26) . Souder et al (12) noted a 21.2-to 24.9-month interval between an initial femoral neck fracture and the subsequent hip fracture. More research into defi ning a tighter interval (and possibly exploring reasons for such varied intervals) may be warranted.
Th e limitations of our study include its retrospective nature and surgeon bias. All retrospective studies are limited by their ability to retrieve data and control variables. Furthermore, the sample size is often diminished due to missing data points. Surgeon bias such as varied experience in interpretation of radiographs and familiarity with surgical techniques also likely aff ected how the fractures were classifi ed and which implant the patient received. Th e scope of this study did not include a number of variables, which potentially aff ected our fi ndings. A prospective study would most likely be required to get accurate data on mental status, ambulatory status, degree of osteoporosis, and current control of diabetes throughout the period of study, all of which would lead to more accurate data and a better understanding of confounding variables.
To summarize, our data showed no diff erence in the rates of contralateral hip fracture when comparing HSSP with CMN. Our results did suggest that patient-related variables such as bisphosphonate use are associated with an increase in the rate of contralateral hip fracture after initial IT/PT fracture; however, these are complex topics and further research would be needed to defi nitively make a statement on these variables. Th e factors of implant choice (HSSP vs CMN) and smoking history did not appear to aff ect the rate of contralateral hip fracture after IT/PT fracture.
